| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 6054- | RES, | SeNPs, | Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota |
| - | in-vivo, | AD, | NA |
| 5781- | RES, | Resveratrol improves health and survival of mice on a high-calorie diet |
| - | in-vivo, | Nor, | NA |
| 5788- | RES, | Calorie restriction-like effects of 30 days of Resveratrol (resVida™) supplementation on energy metabolism and metabolic profile in obese humans |
| - | Trial, | Nor, | NA |
| 5797- | RES, | Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution? |
| - | Review, | Nor, | NA |
| 2334- | RES, | Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy |
| - | Review, | Var, | NA |
| 2650- | RES, | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
| - | Review, | Var, | NA |
| 2565- | RES, | https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2007.06788.x |
| - | in-vivo, | Nor, | NA | - | in-vivo, | NA, | NA |
| 2441- | RES, | Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions |
| - | Review, | Var, | NA |
| 3079- | RES, | Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action |
| - | Review, | Var, | NA |
| 3078- | RES, | The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment |
| - | Review, | Pca, | NA |
| 3076- | RES, | Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells |
| - | Review, | Var, | NA |
| 3055- | RES, | Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets |
| - | Review, | Var, | NA |
| 3056- | RES, | Less is more for cancer chemoprevention: evidence of a non-linear dose response for the protective effects of resveratrol in humans and mice |
| - | in-vivo, | Nor, | NA |
| 4357- | RF, | Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies |
| - | Review, | Var, | NA |
| 6810- | RF, | SUMMARY OF SAFETY AND PROBABLE BENEFIT (SSPB) |
| - | Trial, | HCC, | NA |
| 6809- | RF, | Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields |
| - | in-vitro, | GBM, | U251 |
| 6808- | RF, | Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma |
| - | Trial, | HCC, | NA |
| - | vitro+vivo, | HCC, | NA |
| 6935- | RF, | Effects of pulsed electromagnetic fields on benign prostate hyperplasia |
| - | Human, | BPH, | NA |
| 3012- | RosA, | Rad, | Rosmarinic Acid Prevents Radiation-Induced Pulmonary Fibrosis Through Attenuation of ROSMYPT1TGFβ1 Signaling Via miR-19b-3p |
| - | in-vitro, | Nor, | IMR90 |
| 3001- | RosA, | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
| - | Review, | Var, | NA |
| 1742- | RosA, | Rosmarinic acid, a natural polyphenol, has a potential pro-oxidant risk via NADH-mediated oxidative DNA damage |
| - | Analysis, | Var, | NA |
| 1745- | RosA, | Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 3621- | RosA, | Short-Term Study on the Effects of Rosemary on Cognitive Function in an Elderly Population |
| - | Trial, | AD, | NA |
| 7381- | RS, | In-vitro anticancer activity of Rauvolfia tetraphylla extract on mcf-7 breast cancer cell lines |
| - | in-vitro, | BC, | MCF7 |
| 7379- | RS, | Blood pressure-lowering efficacy of reserpine for primary hypertension |
| - | Review, | Nor, | NA |
| 7951- | RT, | BuckWS, | The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives |
| - | Review, | Nor, | NA |
| 7830- | SA, | MBS, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| 4905- | Sal, | Salinomycin as a drug for targeting human cancer stem cells |
| - | Review, | Var, | NA |
| 6451- | SAO, | α-Santalol functionalized chitosan nanoparticles as efficient inhibitors of polo-like kinase in triple negative breast cancer |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 5038- | SAS, | Rad, | Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma |
| - | in-vivo, | Melanoma, | B16-F10 |
| 2548- | SDT, | Sonoporation, a Novel Frontier for Cancer Treatment: A Review of the Literature |
| - | Review, | Var, | NA |
| 2537- | SDT, | Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers |
| - | Review, | Var, | NA |
| 2536- | SDT, | Sonodynamic Therapy: Rapid Progress and New Opportunities for Non-Invasive Tumor Cell Killing with Sound |
| - | Review, | Var, | NA |
| 2549- | SDT, | Landscape of Cellular Bioeffects Triggered by Ultrasound-Induced Sonoporation |
| - | Review, | Var, | NA |
| 2551- | SDT, | Sonoporation: Past, Present, and Future |
| - | Review, | Var, | NA |
| 2142- | Se, | A U-shaped association between selenium intake and cancer risk |
| - | Review, | Var, | NA |
| 2141- | Se, | Selenium and cancer risk: Wide-angled Mendelian randomization analysis |
| - | Review, | Var, | NA |
| 1701- | Se, | An Assessment of Serum Selenium Concentration in Women with Ovarian Cancer |
| - | Human, | Ovarian, | NA |
| 1700- | Se, | Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers |
| - | Review, | Var, | NA |
| 1699- | Se, | Vegetarianism and colorectal cancer risk in a low-selenium environment: effect modification by selenium status? A possible factor contributing to the null results in British vegetarians |
| - | Analysis, | CRC, | NA |
| 1695- | Se, | Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparative Study |
| - | Trial, | CRC, | NA |
| 1690- | Se, | Selenium and cancer: a story that should not be forgotten-insights from genomics |
| - | Review, | Var, | NA |
| 1689- | Se, | Selenium and breast cancer - An update of clinical and epidemiological data |
| - | Analysis, | BC, | NA |
| 4615- | Se, | Rad, | Selenium as an adjuvant for modification of radiation response |
| - | Review, | Nor, | NA |
| 4604- | Se, | AgNPs, | Chit, | The ameliorative effect of selenium-loaded chitosan nanoparticles against silver nanoparticles-induced ovarian toxicity in female albino rats |
| - | in-vivo, | Nor, | NA |
| 4495- | Se, | Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort |
| - | Study, | CRC, | NA |
| 4726- | Se, | Oxy, | Oxygen therapy accelerates apoptosis induced by selenium compounds via regulating Nrf2/MAPK signaling pathway in hepatocellular carcinoma |
| - | in-vivo, | HCC, | NA |
| 4751- | Se, | Chemo, | Selenium Protects Against Toxicity Induced by Anticancer Drugs and Augments Antitumor Activity: A Highly Selective, New, and Novel Approach for the Treatment of Solid Tumors |
| - | in-vivo, | Var, | NA |
| 4757- | Se, | Chemo, | The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients |
| - | Trial, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid